Editas Medicine (EDIT): Sen. Bill Hagerty disclosed a partial sale $15K–$50K
Sen. Bill Hagerty disclosed a partial sale of Editas Medicine in the $15K–$50K range.
- $15,001–$50,000
- Reported range · official band, not an exact amount
- 31 days
- Disclosure lag
- Traded
- Jan 19, 2021
- Disclosed
- Feb 19, 2021
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 19, 2021 · this disclosureCongressDisclosed partial sale of EDIT — reported range $15,001 - $50,000
What came next
How to read Senate eFD periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Editas Medicine
For Editas Medicine, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EDIT page.
Other recent filings by Sen. Bill Hagerty
- Senate eFD periodic transaction report at Datadog (DDOG)Jan 10, 2024
- Senate eFD periodic transaction report at Lemonade (LMND)May 16, 2022
- Senate eFD periodic transaction report at Datadog (DDOG)Jan 10, 2022
- Senate eFD periodic transaction report at Ryman Hospitality Properties (RHP)Jan 10, 2022
- Senate eFD periodic transaction report at RenaissanceRe (RNR)Jan 10, 2022
The full history of Sen. Bill Hagerty is on the profile page.
How this filing works
Explore the data
Other disclosures at Editas Medicine
- SEC Form 4Nov 13, 2026
- SEC Form 4Nov 13, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 4Sep 4, 2025
- SEC Form 4Sep 4, 2025
Everything OQRO holds on this company is on its EDIT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data